Study ID,Study,Experiment Name,Experiment Notes,Strain Ont ID,Strain,Sex,Age,# of Animals,Sample Notes,Clinical Measurement Ont ID,Phenotype,Formula,Clinical Measurement Notes,Average Type,Value,Units,SEM,SD,Method Ont ID,Method,Method Site,Method Duration,Method Notes,Post Insult Type,Post Insult Time Value,Post Insult Time Unit,Conditions,Record ID,Condition 1,Condition 2 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.000546,mg/dl,3.0E-4,6.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,103937,control condition, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.000066,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled hesperidin content diet (1 %) (for 28 days),103938,controlled hesperidin content diet (1 %) (for 28 days), 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood insulin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000358,serum insulin level,,,,0.00012,mg/dl,1.0E-4,3.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),103939,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days), 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood adiponectin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000583,serum adiponectin level,,,,10.38,ng/ml,1.62,3.9682,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,103941,control condition, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood adiponectin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000583,serum adiponectin level,,,,18.26,ng/ml,2.14,5.2419,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled hesperidin content diet (1 %) (for 28 days),103942,controlled hesperidin content diet (1 %) (for 28 days), 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",blood adiponectin amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0000583,serum adiponectin level,,,,22.3,ng/ml,1.65,4.0417,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),103943,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days), 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",liver triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0001598,liver triglyceride level,,,,16.41,mg/g,1.38,3.3803,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,control condition,103971,control condition, 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",liver triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0001598,liver triglyceride level,,,,11.37,mg/g,1.3,3.1843,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled hesperidin content diet (1 %) (for 28 days),103972,controlled hesperidin content diet (1 %) (for 28 days), 2884,"Akiyama S, et al., Biosci Biotechnol Biochem. 2009 Dec;73(12):2779-82. doi: 10.1271/bbb.90576. Epub 2009 Dec 7.",liver triglyceride amount,,RS:0004580,GK/Jcl,male,52 days,6,,CMO:0001598,liver triglyceride level,,,,9.41,mg/g,0.8,1.9596,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days),103973,controlled cyclodextrin (CD)-clathrated hesperetin content diet (4.6 %) (for 28 days), 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004580,GK/Jcl,male,154 days,7,,CMO:0000358,serum insulin level,,,,0.00013,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting,110215,fasting, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood insulin amount,,RS:0004580,GK/Jcl,male,140 days,7,,CMO:0000358,serum insulin level,,,,0.00018,mg/dl,0.0,1.0E-4,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,glucose,30,min,fasting then glucose solution (2 g/kg) (for 0.5 hours),110219,fasting,glucose solution (2 g/kg) (for 0.5 hours) 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood glucagon-like peptide amount,,RS:0004580,GK/Jcl,male,154 days,7,,CMO:0003639,serum glucagon-like peptide 1 level,,,,21.5,pg/ml,3.55,9.3924,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,fasting,110223,fasting, 3167,"Mizukami H, et al., Pancreas. 2013 Jul;42(5):786-94. doi: 10.1097/MPA.0b013e318287c9b5.",blood glucagon-like peptide amount,,RS:0004580,GK/Jcl,male,154 days,7,,CMO:0003639,serum glucagon-like peptide 1 level,,,,43.1,pg/ml,4.95,13.0965,MMO:0000075,enzyme linked immunosorbent assay,,0.0,,,,,vildagliptin (30 mg/kg/d) (for 106 days) then fasting,110224,vildagliptin (30 mg/kg/d) (for 106 days),fasting